XML 38 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Details) (USD $)
3 Months Ended 9 Months Ended
Oct. 27, 2012
Oct. 29, 2011
Oct. 27, 2012
Oct. 29, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total compensation expense $ 2,023,000 $ 2,275,000 $ 5,459,000 $ 6,354,000
Related tax benefit (761,000) (855,000) (2,053,000) (2,389,000)
Compensation expense, net of tax 1,262,000 1,420,000 3,406,000 3,965,000
Unrecognized compensation cost 17,300,000   17,300,000  
Unrecognized compensation cost, period for recognition (in years)     2 years 6 months 0 days  
Stock Options and SARs [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total compensation expense 765,000 1,062,000 2,305,000 3,185,000
Stock Options and SARs [Abstract]        
Award vesting period (in years)     4 years  
Percentage of awards vesting each year (in hundredths)     25.00%  
Award vesting rights     each of the first four years following the date of grant  
Award expiration period (in years)     7Y  
Share Based Compensation Stock Options and SARs Outstanding [Roll Forward]        
Beginning Balance (in shares)     4,004,257  
Exercised (in shares)     (1,256,883)  
Forfeited (in shares)     (700,787)  
Ending Balance (in shares) 2,046,587   2,046,587  
Vested or expected to vest (in shares) 1,884,104   1,884,104  
Exercisable (in shares) 1,234,173   1,234,173  
Stock Options and SARs, Weighted Average Exercise Price [Abstract]        
Beginning Balance (in dollars per share)     $ 16.10  
Exercised (in dollars per share) $ 14.59   $ 14.59  
Forfeited (in dollars per share) $ 16.74   $ 16.74  
Ending Balance (in dollars per share) $ 16.81   $ 16.81  
Vested or expected to vest (in dollars per share) $ 16.88   $ 16.88  
Exercisable (in dollars per share) $ 17.34   $ 17.34  
Stock Options and SARs, Weighted Average Remaining Contractual Term (years) [Abstract]        
Ending Balance (in years) 3.3   3.3  
Vested And Expected To Vest (in years) 3.2   3.2  
Exercisable (in years) 2.4   2.4  
Stock Options and SARs, Aggregate Intrinsic Value [Abstract]        
Ending Balance 14,433,000   14,433,000  
Vested And Expected To Vest 13,154,000   13,154,000  
Exercisable 8,042,000   8,042,000  
Aggregate intrinsic value     5,700,000 4,200,000
Nonvested Stock [Abstract]        
Award vesting period (in years)     4 years  
Non-vested Stock Options And SARs [Member]
       
Nonvested Stock Option Awards and SARs, Outstanding [Roll Forward]        
Non-vested (in shares)     1,794,350  
Vested (in shares)     (628,961)  
Forfeited (in shares)     (352,975)  
Non-vested (in shares) 812,414   812,414  
Nonvested Stock Option Awards and SARs, Weighted Average Grant Date Fair Value [Abstract]        
Non-vested (in dollars per share)     $ 6.72  
Vested (in dollars per share)     $ 6.22  
Forfeited (in dollars per share)     $ 6.28  
Non-vested (in dollars per share) $ 7.30   $ 7.30  
Non-vested Stock Options [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total compensation expense 774,000 693,000 2,229,000 1,787,000
Stock Options and SARs [Abstract]        
Weighted average grant date fair value $ 16.19   $ 16.19  
Nonvested Stock [Abstract]        
Nonvested stock conversion ratio     one for one  
Nonvested stock, outstanding [Roll Forward]        
Beginning Balance (in shares)     376,965  
Granted (in shares)     493,665  
Vested (in shares)     (136,060)  
Forfeited (in shares)     (86,081)  
Ending Balance (in shares) 648,489   648,489  
Nonvested Stock, Weighted Average Grant Date Fair Value [Roll Forward]        
Beginning Balance (in dollars per share)     $ 16.68  
Granted (in dollars per share)     $ 16.10  
Vested (in dollars per share)     $ 16.16  
Forfeited (in dollars per share)     $ 17.89  
Ending Balance (in dollars per share) $ 16.19   $ 16.19  
Aggregate intrinsic value     2,200,000  
Number of shares issued (in shares)     120,105  
Performance Shares [Abstract]        
Target Shares Granted (in shares)     493,665  
Target Shares Forfeited (in shares)     (86,081)  
Target Shares Outstanding (in shares) 648,489   648,489  
Weighted Average Grant Date Fair Value per Share (in dollars per share) $ 16.19   $ 16.19  
Number of shares vested (in shares)     (136,060)  
Aggregate intrinsic value     2,200,000  
Number of shares issued (in shares)     120,105  
Non-vested Stock Options [Member] | Minimum [Member]
       
Stock Options and SARs [Abstract]        
Award vesting period (in years)     1 year  
Nonvested Stock [Abstract]        
Award vesting period (in years)     1 year  
Non-vested Stock Options [Member] | Maximum [Member]
       
Stock Options and SARs [Abstract]        
Award vesting period (in years)     4 years  
Nonvested Stock [Abstract]        
Award vesting period (in years)     4 years  
Performance Shares [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total compensation expense 484,000 520,000 925,000 1,382,000
Nonvested stock, outstanding [Roll Forward]        
Beginning Balance (in shares)     171,225  
Granted (in shares)     243,100  
Vested (in shares)     40,314  
Forfeited (in shares)     (59,425)  
Ending Balance (in shares) 354,900   354,900  
Nonvested Stock, Weighted Average Grant Date Fair Value [Roll Forward]        
Aggregate intrinsic value     700,000  
Number of shares issued (in shares)     29,650  
Performance Shares [Abstract]        
Number of shares issuable, minimum (in shares)     0  
Multiple of the number of granted shares outstanding for issuable shares     2  
Performance cycle (in years)     3 years  
Target Shares Granted (in shares)     243,100  
Target Shares Forfeited (in shares)     (59,425)  
Target Shares Outstanding (in shares) 354,900   354,900  
Number of shares vested (in shares)     40,314  
Aggregate intrinsic value     700,000  
Number of shares issued (in shares)     29,650  
Tax liability paid by recipient of award $ 200,000   $ 200,000  
SARs [Member]
       
Significant weighted average assumptions [Abstract]        
Expected volatility, minimum (in hundredths)       63.40%
Expected volatility, maximum (in hundredths)       63.70%
Weighted average volatility (in hundredths)       63.60%
Risk-free rate, minimum (in hundredths)       1.50%
Risk-free rate, maximum (in hundredths)       1.90%
Expected life (in years)       4 years 3 months 18 days
Stock Options and SARs [Abstract]        
Weighted average grant date fair value   $ 8.69   $ 8.69
Nonvested Stock, Weighted Average Grant Date Fair Value [Roll Forward]        
Ending Balance (in dollars per share)   $ 8.69   $ 8.69
Performance Shares [Abstract]        
Weighted Average Grant Date Fair Value per Share (in dollars per share)   $ 8.69   $ 8.69
SARs [Member] | Minimum [Member]
       
Significant weighted average assumptions [Abstract]        
Expected dividend yield (in hundredths)       1.60%
SARs [Member] | Maximum [Member]
       
Significant weighted average assumptions [Abstract]        
Expected dividend yield (in hundredths)       1.90%
Stock Options [Member]
       
Stock Options and SARs [Abstract]        
Award expiration period (in years)     10Y  
Performance Share Grant 2010 [Member]
       
Stock Options and SARs [Abstract]        
Weighted average grant date fair value $ 19.75   $ 19.75  
Nonvested stock, outstanding [Roll Forward]        
Beginning Balance (in shares)     107,000  
Forfeited (in shares)     (30,000)  
Ending Balance (in shares) 77,000   77,000  
Nonvested Stock, Weighted Average Grant Date Fair Value [Roll Forward]        
Ending Balance (in dollars per share) $ 19.75   $ 19.75  
Performance Shares [Abstract]        
Target Shares Forfeited (in shares)     (30,000)  
Target Shares Outstanding (in shares) 77,000   77,000  
Weighted Average Grant Date Fair Value per Share (in dollars per share) $ 19.75   $ 19.75  
Performance Share Grant 2011 [Member]
       
Stock Options and SARs [Abstract]        
Weighted average grant date fair value $ 25.00   $ 25.00  
Nonvested stock, outstanding [Roll Forward]        
Beginning Balance (in shares)     64,225  
Forfeited (in shares)     (24,425)  
Ending Balance (in shares) 39,800   39,800  
Nonvested Stock, Weighted Average Grant Date Fair Value [Roll Forward]        
Ending Balance (in dollars per share) $ 25.00   $ 25.00  
Performance Shares [Abstract]        
Target Shares Forfeited (in shares)     (24,425)  
Target Shares Outstanding (in shares) 39,800   39,800  
Weighted Average Grant Date Fair Value per Share (in dollars per share) $ 25.00   $ 25.00  
Performance Share Grant 2012 [Member]
       
Stock Options and SARs [Abstract]        
Weighted average grant date fair value $ 18.04   $ 18.04  
Nonvested stock, outstanding [Roll Forward]        
Granted (in shares)     243,100  
Forfeited (in shares)     (5,000)  
Ending Balance (in shares) 238,100   238,100  
Nonvested Stock, Weighted Average Grant Date Fair Value [Roll Forward]        
Ending Balance (in dollars per share) $ 18.04   $ 18.04  
Performance Shares [Abstract]        
Target Shares Granted (in shares)     243,100  
Target Shares Forfeited (in shares)     (5,000)  
Target Shares Outstanding (in shares) 238,100   238,100  
Weighted Average Grant Date Fair Value per Share (in dollars per share) $ 18.04   $ 18.04  
2001 Equity Incentive Plan [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares reserved for issuance upon exercise of awards 12,375,000   12,375,000  
2008 Equity Incentive Plan [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares reserved for issuance upon exercise of awards 4,550,000   4,550,000